• Home
  • News

Zoetis Receives Conditional License from USDA for Avian Influenza Vaccine, H5N1 Subtype, Killed Virus

Wednesday, March 30, 2016 7:27 am EDT

Dateline:

Florham Park
"We stand ready to help our customers implement a vaccination strategy, should the USDA determine that is the best course of action for the industry"

FLORHAM PARK, N.J., March 30, 2016 — Zoetis Inc. today announced that the U.S. Department of Agriculture (USDA) has granted the company a conditional license for Avian Influenza Vaccine, H5N1 Subtype, Killed Virus*. The vaccine is intended for use in chickens as an aid in the prevention of disease caused by avian influenza H5N1.

“We stand ready to help our customers implement a vaccination strategy, should the USDA determine that is the best course of action for the industry,” said Jon Schaeffer, DVM, Director of U.S. Poultry Veterinary Services at Zoetis. “In the meantime, we will continue to support the USDA and our customers in helping prevent future avian influenza outbreaks.”

An outbreak of highly pathogenic avian influenza (HPAI) during the spring and summer of 2015 was the largest animal health emergency in the country’s history, according to USDA. More than 49 million birds have died, with HPAI detected in migratory birds as well as commercial and backyard flocks in 21 states, as a result of last year’s outbreak1.

The conditional license was granted on the demonstration of a reasonable expectation of efficacy based on serology data. Zoetis will pursue the current opportunity to supply vaccines to the USDA’s National Veterinary Stockpile. For more information about this announcement, please reach out to your Zoetis representative.

*This product license is conditional. Efficacy and potency studies are in progress.

About Zoetis

Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2015, the company generated annual revenue of $4.8 billion with approximately 9,000 employees. For more information, visit www.zoetisUS.com.

1 2016 HPAI Preparedness and Response Plan USDA APHIS. https://www.aphis.usda.gov/animal_health/downloads/animal_diseases/ai/hpai-preparedness-and-response-plan-2015.pdf  Page 3. Accessed March 1, 2016.